Call for papers: Adult congenital heart disease
Published in Healthcare & Nursing and General & Internal Medicine

BMC Cardiovascular Disorders is calling for submissions to our Collection on Adult congenital heart disease (ACHD). Millions of people are living with ACHD as more children with congenital heart disease reach adulthood. ACHD encompasses a wide range of structural and functional heart abnormalities, including blood vessel (e.g. aortic coarctation, aortic and pulmonary artery stenosis, patent ductus arteriosus, transposition of the great arteries and anomalous pulmonary venous return), heart valve (e.g. bicuspid aortic valve disease, Ebstein’s anomaly and mitral valve prolapse), and septal defects (e.g. atrial septal defect, patent foramen ovale and ventricular septal defect), that develop before birth but are not diagnosed until adulthood.
In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders is launching a new Collection on Adult congenital heart disease to bring together basic and clinical research to develop our understanding of ACHD and improve the care and outcomes for patients living with this condition. We welcome submissions on topics such as:
• Advances in diagnosis and imaging
• Long-term outcomes and quality of life
• Management of arrhythmias and heart failure
• Innovative treatments and surgical techniques
Living with ACHD can present significant challenges for patients, including the need for lifelong monitoring, multiple surgeries, and a higher risk of heart failure as well as other cardiovascular complications. We hope this Collection can serve as a platform for researchers to showcase the latest advances in the epidemiology, pathophysiology, diagnosis, and treatment of ACHD.
Meet the Guest Editors
Niraj Nirmal Pandey: All India Institute of Medical Sciences, IndiaDr Niraj Nirmal Pandey is a physician researcher in the field of cardiovascular and interventional radiology and currently works as Assistant Professor of Cardiac Radiology at the All India Institute of Medical Sciences, New Delhi, India. His work focuses on imaging in congenital heart diseases and coronary heart disease as well as on novel intra-arterial embolization/recanalization therapies. He holds an MD (Radiodiagnosis) from the University of Delhi and a postdoctoral (DM) degree in Cardiovascular Radiology and Endovascular Interventions from AIIMS, New Delhi. He has over 225 publications including multiple CT-angiography based prevalence studies in congenital heart diseases and descriptions of hitherto undescribed anatomical variations/anomalies of the cardiovascular system. He currently works on the utilization of virtual dissection techniques in clarifying the anatomy of the malformed heart.
Elaheh Malakan Rad: Tehran University of Medical Sciences, Iran
Dr Elaheh Malakan Rad, MD, FACC, is a senior professor of pediatric interventional cardiology at Children's Medical Center, Tehran University of Medical Sciences. She is a Senior Editorial Board Member of BMC Cardiovascular Disorders, a member of the Iranian National Board of Examiners of Pediatric Cardiology and Medical Education, and a GBD collaborator. With over 25 years of academic experience, her expertise in pediatric cardiology includes teaching, research, and patient care. She has over 80 published papers in peer-reviewed journals and holds two joint provisional patents in the US Patent Office for transcatheter devices in congenital heart disease interventions.
Christoph Sinning: University Heart & Vascular Center Hamburg, Germany
Dr Christoph Sinning is senior physician at the Department of Cardiology at the University Heart & Vascular Center Hamburg, Germany. His main areas of work are cardiovascular imaging with a focus on echocardiography, treatment of adults with congenital heart disease, and cardiac devices like pacemakers and ICDs. His current scientific work is focusing on the use of echocardiography in detecting the outcome of patients undergoing EP procedures and improving detection of candidates for cardiac resynchronization therapy. Another area of focus for his scientific work is the outcome of advanced heart failure in adults with congenital heart disease.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Adult congenital heart disease" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 24 April 2024
Follow the Topic
-
BMC Cardiovascular Disorders
This journal is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of disorders of the heart and circulatory system.
Related Collections
With collections, you can get published faster and increase your visibility.
Women and cardiovascular disease: Addressing the gender gap
BMC Cardiovascular Disorders is calling for submissions to our Collection on Women and cardiovascular disease: Addressing the gender gap. Cardiovascular disease (CVD) is the leading cause of death among women worldwide, yet women remain underrepresented in cardiovascular research. Studies have shown that women experience worse outcomes following heart attacks and are more likely to be misdiagnosed or undertreated due to differences in disease presentation and a lack of sex-specific research.
To address this gap, BMC Cardiovascular Disorders is seeking submissions for a special collection focused on women and cardiovascular disease. We invite research exploring women's challenges in CVD diagnosis, treatment, and prevention. Topics of interest include, but are not limited to, sex differences in CVD risk factors, the molecular mechanisms underlying CVD, clinical presentation, and treatment outcomes, as well as barriers to women's participation in clinical trials.
This collection also welcomes research on innovative strategies to improve cardiovascular care for women, such as public health campaigns, policy changes, and healthcare professional education. We encourage submissions highlighting interdisciplinary approaches, novel technologies, and interventions aimed at reducing the global burden of CVD in women.
This Collection is in support of SDG 3: Good Health & Well-Being and SDG 10: Reduced Inequalities.
Publishing Model: Open Access
Deadline: Aug 19, 2025
Cancer and cardiovascular disorders
The interplay between cancer and cardiovascular disorders is a growing area in medical research, as the prevalence of both conditions continues to rise globally. Patients diagnosed with cancer often face a myriad of challenges, not only from the disease itself but also from the treatments employed, such as chemotherapy, which can have deleterious effects on cardiovascular health. Understanding the intricate relationships between cancer and cardiovascular disease, including shared risk factors and the impact of cancer therapies on heart function, is crucial for improving patient outcomes and quality of life.
The urgency of this research lies in the increasing incidence of comorbidities, as patients with cancer are at a heightened risk for developing cardiovascular disorders. Advances in precision medicine, biomarker identification, and imaging technologies are providing new insights into how cancer therapies impact cardiovascular health. Furthermore, multidisciplinary approaches that integrate oncology and cardiology are essential to formulate strategies for prevention, early detection, and management of cardiovascular complications in cancer patients.
If research in this area continues to expand, we may see significant improvements in the management of patients with concurrent cancer and cardiovascular diseases. This could involve the development of tailored therapeutic regimens that minimize cardiovascular risks associated with cancer treatment, as well as enhanced screening protocols that identify at-risk patients earlier. Ultimately, advancements in our understanding of these comorbidities will pave the way for holistic care strategies that prioritize the overall health and well-being of patients.
- Impact of chemotherapy on cardiovascular health
- Shared risk factors between cancer and cardiovascular disease
- Management strategies for comorbidities
- Role of biomarkers in predicting cardiovascular outcomes
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
Publishing Model: Open Access
Deadline: Mar 06, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in